FDA Clears Tecentriq + Lurbinectedin for First-Line Maintenance in Small Cell Lung Cancer

FDA Approves Tecentriq Plus Lurbinectedin as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer In a landmark decision for the lung cancer community, Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that the U.S.…

Read MoreFDA Clears Tecentriq + Lurbinectedin for First-Line Maintenance in Small Cell Lung Cancer

Carenet Health Recognized as Major Contender in 2025 Everest Group Care Management PEAK Matrix®

Carenet Health Recognized as Major Contender in Everest Group’s 2025 PEAK Matrix® for Clinical and Care Management Operations Platforms Carenet Health has been formally recognized as a Major Contender in the 2025 PEAK Matrix® Assessment conducted by Everest Group for…

Read MoreCarenet Health Recognized as Major Contender in 2025 Everest Group Care Management PEAK Matrix®

$1M Stephenson Prize Awarded to Dr. Frank McCormick for Pancreatic Cancer Research

Dr. Frank McCormick Receives Inaugural $1 Million Stephenson Global Prize for Pancreatic Cancer Research In a landmark moment for the global cancer research community, Dr. Frank McCormick has been awarded the inaugural Stephenson Global Prize, recognizing his groundbreaking contributions to…

Read More$1M Stephenson Prize Awarded to Dr. Frank McCormick for Pancreatic Cancer Research